York Hospital | MedPath

Hilo Secures $42 Million Series B Funding to Revolutionize Blood Pressure Monitoring

14 days ago

• Hilo (formerly Aktiia) has raised $42 million in Series B funding to advance its cuffless blood pressure monitoring technology, bringing total financing to over $100 million. • The funding round was co-led by Earlybird Health and Wellington Partners, with participation from new investors Kfund and naturalX Health Ventures, alongside existing investors including Khosla Ventures. • With 120,000 devices sold and regulatory approvals in multiple countries, Hilo aims to address the global hypertension crisis where only 20% of affected individuals have their blood pressure under control.

Helix Research Network Reveals Genomic Screening Improves Patient Care and Risk Identification at ACMG 2025

2 months ago

• Helix's population genomics research demonstrates that genomic screening accurately identifies high-risk individuals and improves adherence to recommended care protocols across multiple conditions. • The Helix Research Network, North America's largest precision clinical research network, presented findings showing improved clinical management for conditions including familial hypercholesterolemia and hereditary breast cancer. • Real-world evidence from Helix's multi-health system studies reveals automated variant interpretation achieves accuracy equivalent to standard ACMG/AMP guidelines, potentially streamlining genetic testing implementation.